Mylan N.V. (now part of Viatris)

Mylan N.V. was a global pharmaceutical company known for producing a wide range of generic and specialty medicines, making healthcare more affordable and accessible. In 2020, Mylan merged with Pfizer’s Upjohn division to form Viatris, creating one of the world's largest pharmaceutical companies. Viatris continues to develop and distribute medications for various health conditions, focusing on innovation, quality, and expanding access to essential medicines worldwide. The merger aimed to strengthen their ability to meet global health needs efficiently and sustainably.